Hepatocellular carcinoma in Central Europe: prognostic features and survival. - Wikidata - wikimedia - TriplyDB

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

http://www.wikidata.org/entity/Q35362361

about

Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review Management of hepatocellular carcinoma with portal vein thrombosis Cancer and liver cirrhosis: implications on prognosis and management Challenges of advanced hepatocellular carcinoma A systematic review on the safety and effectiveness of yttrium-90 radioembolization for hepatocellular carcinoma with portal vein tumor thrombosis Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection.Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.The prognostic significance of clinical and pathological features in hepatocellular carcinoma.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.Octreotide treatment of patients with hepatocellular carcinoma--a retrospective single centre controlled study.Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus.Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis.Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding.Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90.A Review of Non-operative Treatments for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus.Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges.Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus.Clinical characteristics and time trends in etiology of hepatocellular cancer in Germany.Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.

P2860

Q26738533-F339B680-6E8B-40B3-8AF5-D86C598FFE82 Q26772299-2C9D1EC8-C483-409E-877B-0CB44919AF62 Q26996578-67F58010-1293-41AA-9E3A-5A4A2CBA463E Q28068579-0F94197E-7DC5-4B2C-BDAC-E0C9DFE466EA Q28076867-58D8BFC2-0DA0-418A-9865-E51B88F13661 Q28079066-30D44661-4A37-4B56-8E29-2047CE1FD325 Q30724968-F1AE0C9E-F95F-419F-B2D7-4768150875E3 Q33584901-3475A4A3-E48F-41F5-B5AB-A81A04A533D8 Q33621633-74AF7E7F-73C9-46AF-A2A4-39611D815572 Q33627217-53B48C8F-48BF-494D-88B7-1926B8C400BE Q33805289-29237246-AD25-4972-8D1B-BE7021F0E19D Q33951214-FA8CB1CA-128D-4246-AD2F-8A676BAD0242 Q34061430-0221116E-086E-4F5B-84C7-74EA17DD8059 Q34446810-09F332F9-8BD4-4488-B19F-52509D4A52F5 Q34582844-22285B57-02A4-465A-8C8F-C3FC6667237C Q35113002-649AD6EA-148E-4111-A2FF-A11400F1479F Q35597216-151E15ED-C08F-4283-A98A-28DC521AB36B Q35597241-959BEF6B-0DA6-4C4B-ABA3-1C5DC44A7679 Q35715947-512A2092-3F45-49CE-86C5-D572C7F8D948 Q35824064-F92614C5-7DBD-4E74-8BE7-9565F6DC5801 Q35879110-D8EB477A-9154-482D-A240-D48DBE158FA3 Q36009432-C9384E26-550B-431E-BF22-06A3BDF2D4AA Q36179125-07938F34-193E-472F-868C-72D1703F4EB2 Q36623383-3E30E7E1-34FE-4743-B8E3-8597CCECB428 Q36688945-F7D35F9F-F19C-4641-BD9F-0413A9F7C3AE Q36844469-F6329095-4EF3-4071-A1C1-ABA83C0FAD4B Q36905681-5802565B-3919-44AF-8979-EC333595D2C4 Q37263149-59F6E95B-D4E3-4746-BBAA-976690A1306C Q37426913-D9295C36-E211-421B-9A36-31D866E4CF92 Q37474664-F6FD7F78-934F-4C09-8FD5-02FB55DDCCD9 Q37483280-07D17A4D-96A0-469E-A92E-5BEE033ECC94 Q37601096-1C922BDD-B5D1-40BC-9275-2C0BC67ED7B4 Q37629729-A50083F1-6D7E-414F-944E-E993E3EADF77 Q37645070-253C9A84-26BC-4C67-A2AF-C1225FD520F6 Q38101443-5AAE9B46-FA44-4FE8-8DCC-086A976A3E0D Q38665389-C3040BD7-3355-4FC7-A319-09B24B7E5D2B Q39254708-E61A311E-0A48-40CC-831F-899A0222D4F7 Q39375838-041212C9-1897-4C92-9047-738810FC889E Q39441537-9B6F0133-92D3-4363-BCC6-FFA3F9EE74FB Q41118844-F88147EE-7518-4E10-AD3C-5F0E61D2E1F2

P2860

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

http://www.wikidata.org/entity/Q35362361

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

@ast

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

@en

type

label

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

@ast

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

@en

prefLabel

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

@ast

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

@en

P1433

Q35362361-1EBFAF78-EABD-4843-8DA7-B698E1FA36F3

P1476

Q35362361-319B6DDD-4CB7-402A-A569-DBDEDDB1A0D2

P2093

Q35362361-2F6D7AE2-2DF1-4852-AAE7-0A42E4C39D97

Q35362361-6EC7E5ED-427A-4051-8BBB-01B2867FEBCD

Q35362361-9586E5C6-12D8-4885-892E-5A473A10070C

Q35362361-9F89CFE3-A28D-4DBC-B6D5-4E2F7E5FD093

Q35362361-AD072D0A-6A57-41A3-9B89-A8B6009B39AA

Q35362361-E432BC8E-095F-410C-9453-E73B319BAA74

P2860

Q35362361-0573DDD1-5E43-4AA8-8D75-19984A286AB9

Q35362361-0649B32D-2507-42CA-B189-ABA60B3E07CD

Q35362361-076D8414-5FB4-40CC-A2F5-30B813F2B6EB

Q35362361-1D066E2D-6F44-4971-9D22-2A0DB46F6F08

Q35362361-22174CB2-01B5-44AB-ADBD-4FDAC2C1B6BB

Q35362361-2F10193A-B1F8-408D-BCC3-F777705C101D

Q35362361-34DAF580-8ACA-4118-9531-B57220D1DC84

Q35362361-3CD47678-E3FC-4A19-8DDE-D10B1D811A8F

Q35362361-6927ED27-0022-4A59-BA51-C93F964EBD54

Q35362361-79688C99-E647-4E46-B35D-4983D1C58143

P304

Q35362361-CEAA8021-E229-4EE9-A079-532D3208D042

P31

Q35362361-A46AFD31-E758-4C3D-B7A7-6F464EADFC95

P356

Q35362361-2355E618-8985-4904-AEE2-C2B0B1AA9763

P407

Q35362361-DACB4467-E88B-4650-AFAE-4D6A570DBA48

P433

Q35362361-A18CBDF6-79C7-46F0-B55D-5E6D08A18DE5

P478

Q35362361-2F43B1C3-3934-44E5-90EC-4494C6ECDCC9

P577

Q35362361-10A97442-3069-4D2E-989A-117B0E990A45

P5875

Q35362361-1064C323-FC49-4808-B72B-8D4DA4EC3AF4

P698

Q35362361-F1FA7719-79BE-4045-B27D-5573339A6D4E

P932

Q35362361-FB595EB7-A952-4E5F-A917-F05F631CB820

P356

P1433

P1476

Hepatocellular carcinoma in Central Europe: prognostic features and survival.

@en

P2093

Ferenci P

http://www.w3.org/2001/XMLSchema#string

Gangl A

http://www.w3.org/2001/XMLSchema#string

Kutilek M

http://www.w3.org/2001/XMLSchema#string

Müller C

http://www.w3.org/2001/XMLSchema#string

Oesterreicher C

http://www.w3.org/2001/XMLSchema#string

Schöniger-Hekele M

http://www.w3.org/2001/XMLSchema#string

P2860

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Hepatocellular carcinoma: from gene to public health.

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Treatment of small hepatocellular carcinomas.

Hepatocellular carcinoma. A worldwide problem and the major risk factors.

NIH conference. Hepatocellular carcinoma.

Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients.

Prognostic factors for survival in hepatocellular carcinoma.

Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age.

Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization.

P304

103-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.48.1.103

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12212178

http://www.w3.org/2001/XMLSchema#string

P698

11115830

http://www.w3.org/2001/XMLSchema#string

P932

1728163

http://www.w3.org/2001/XMLSchema#string